عنوان
پدید آورنده
موضوع
رده
RA401.A3 B74 2009eb
RA401
.
A3
B74
2009eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0309120896
(Number (ISBN
1282083554
(Number (ISBN
6612083557
(Number (ISBN
9780309120890
(Number (ISBN
9781282083554
(Number (ISBN
9786612083556
Erroneous ISBN
0309120888
Erroneous ISBN
9780309120883
NATIONAL BIBLIOGRAPHY NUMBER
Number
b703936
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Breakthrough business models :
General Material Designation
[Book]
Other Title Information
drug development for rare and neglected diseases and individualized therapies: workshop summary /
First Statement of Responsibility
[edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Washington, D.C. :
Name of Publisher, Distributor, etc.
National Academies Press,
Date of Publication, Distribution, etc.
©2009.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xviii, 132 pages)
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references.
CONTENTS NOTE
Text of Note
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
0
SUMMARY OR ABSTRACT
Text of Note
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
OTHER EDITION IN ANOTHER MEDIUM
Title
Breakthrough business models.
International Standard Book Number
0309120888
PARALLEL TITLE PROPER
Parallel Title
Drug development for rare and neglected diseases and individualized therapies
TOPICAL NAME USED AS SUBJECT
Drugs-- United States-- Design.
Orphan drugs-- Government policy-- United States.
Pharmaceutical policy-- United States.
Models, Economic-- United States.
Orphan Drug Production-- economics-- United States.
Orphan Drug Production-- trends-- United States.
Research-- economics-- United States.
Research-- trends-- United States.
Drugs-- Design.
MEDICAL-- Allied Health Services-- General.
Orphan drugs-- Government policy.
Pharmaceutical policy.
GEOGRAPHICAL NAME USED AS SUBJECT
United States.
7
(SUBJECT CATEGORY (Provisional
MED-- 003000
DEWEY DECIMAL CLASSIFICATION
Number
362
.
17/820973
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RA401
.
A3
Book number
B74
2009eb
OTHER CLASS NUMBERS
Class number
2009
G-098
Class number
QV
736
Book Number
W835b
2009
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Giffin, Robert B.
Robinson, Sally.
Wizemann, Theresa M.
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.
ORIGINATING SOURCE
Date of Transaction
20201207192429.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
